Literature DB >> 27287365

Synthesis of 1H-pyrrolo[3,2-h]quinoline-8-amine derivatives that target CTG trinucleotide repeats.

Jun Matsumoto1, Jinxing Li1, Chikara Dohno1, Kazuhiko Nakatani1.   

Abstract

We describe a new molecular design, synthesis, and investigation of small molecules that bind to CTG trinucleotide repeats in DNA. 1H-Pyrrolo[3,2-h]quinoline-8-amine (PQA) has a tricyclic aromatic system with unique non-linear hydrogen-bonding surface complementary to thymine. We have synthesized a series of PQA derivatives with different alkylamino linkers. These PQAs showed binding to pyrimidine bulge DNAs and CNG (N=T and C) repeats depending on the linker structure, while quinoline derivatives lacking the pyrrole ring showed much lower binding affinity. PQA is a useful molecular unit for both CTG and CCG repeat binding.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CTG repeat; Mismatch base pair; Small molecule ligand

Mesh:

Substances:

Year:  2016        PMID: 27287365     DOI: 10.1016/j.bmcl.2016.05.062

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

Review 1.  Exploring the Potential of Small Molecule-Based Therapeutic Approaches for Targeting Trinucleotide Repeat Disorders.

Authors:  Arun Kumar Verma; Eshan Khan; Sonali R Bhagwat; Amit Kumar
Journal:  Mol Neurobiol       Date:  2019-08-09       Impact factor: 5.590

2.  Small molecule targeting r(UGGAA)n disrupts RNA foci and alleviates disease phenotype in Drosophila model.

Authors:  Tomonori Shibata; Konami Nagano; Morio Ueyama; Kensuke Ninomiya; Tetsuro Hirose; Yoshitaka Nagai; Kinya Ishikawa; Gota Kawai; Kazuhiko Nakatani
Journal:  Nat Commun       Date:  2021-01-11       Impact factor: 14.919

3.  The Dimeric Form of 1,3-Diaminoisoquinoline Derivative Rescued the Mis-splicing of Atp2a1 and Clcn1 Genes in Myotonic Dystrophy Type 1 Mouse Model.

Authors:  Jun Matsumoto; Masayuki Nakamori; Tatsumasa Okamoto; Asako Murata; Chikara Dohno; Kazuhiko Nakatani
Journal:  Chemistry       Date:  2020-10-06       Impact factor: 5.236

4.  Possibilities and challenges of small molecule organic compounds for the treatment of repeat diseases.

Authors:  Kazuhiko Nakatani
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2022       Impact factor: 3.493

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.